Morgan Stanley’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29M | Buy |
|
|||||
|
2025
Q1 | $1.84M | Buy |
|
|||||
|
2024
Q4 | $1.29M | Buy |
|
|||||
|
2024
Q3 | $499K | Buy |
|
|||||
|
2024
Q2 | $129K | Buy |
|
|||||
|
2024
Q1 | $155K | Sell |
|
|||||
|
2023
Q4 | $450K | Sell |
|
|||||
|
2023
Q3 | $446K | Sell |
|
|||||
|
2023
Q2 | $803K | Sell |
|
|||||
|
2023
Q1 | $1.38M | Buy |
|
|||||
|
2022
Q4 | $1.4M | Sell |
|
|||||
|
2022
Q3 | $355K | Buy |
|
|||||
|
2022
Q2 | $311K | Buy |
|
|||||
|
2022
Q1 | $183K | Buy |
|
|||||
|
2021
Q4 | $293K | Sell |
|
|||||
|
2021
Q3 | $930K | Sell |
|
|||||
|
2021
Q2 | $2.59M | Sell |
|
|||||
|
2021
Q1 | $3.18M | Sell |
|
|||||
|
2020
Q4 | $4.26M | Buy |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $2.37M | Buy |
|
|||||
|
2020
Q1 | $1.12M | Buy |
|
|||||
|
2019
Q4 | $17K | Sell |
|
|||||
|
2019
Q3 | $14K | Buy |
|
|||||
|
2019
Q2 | $18K | Sell |
|
|||||
|
2019
Q1 | $1.09M | Sell |
|
|||||
|
2018
Q4 | $4.96M | Sell |
|
|||||
|
2018
Q3 | $7.86M | Buy |
|
|||||
|
2018
Q2 | $2.12M | Buy |
|
|||||
|
2018
Q1 | $707K | Buy |
|
|||||
|
2017
Q4 | $573K | Buy |
|
|||||
|
2017
Q3 | $491K | Buy |
|
|||||
|
2017
Q2 | $322K | Buy |
|
|||||
|
2017
Q1 | $243K | Sell |
|
|||||
|
2016
Q4 | $255K | Buy |
|
|||||
|
2016
Q3 | $226K | Buy |
|
|||||
|
2016
Q2 | $147K | Buy |
|
|||||
|
2016
Q1 | $5K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $488K | Sell |
|
|||||
|
2015
Q2 | $625K | Sell |
|
|||||
|
2015
Q1 | $1.01M | Buy |
|
|||||
|
2014
Q4 | $901K | Buy |
|
|||||
|
2014
Q3 | $272K | Buy |
|